GeneKang
GeneKang is a biotechnology company founded in 2014 in Beijing, dedicated to improving public health through genome technology. The company specializes in whole genome data analysis, interpretation, and application development, offering a one-stop service from gene sequencing to data interpretation and application. Recognized as a high-tech enterprise, GeneKang has participated in national projects like precision medicine and has developed proprietary cloud-based genome analysis and interpretation services (GAIC) to provide faster, lower-cost genome data analysis and interpretation.
Industries
Nr. of Employees
small (1-50)
GeneKang
Beijing: No. 6 Taiping Street, Fuli Morgan Center, E-1012, Xicheng District; Hangzhou: No. 459 Qiqi North Road, Heda High-tech Life Science Center, Rooms 1307-1308
Products
Cloud genomic analysis and interpretation platform
Cloud-hosted platform for genome-scale data analysis and interpretation intended to accelerate throughput and reduce per-sample cost.
Online gene-product customization engine
Browser-based tool providing selection from thousands of interpretation items, cost estimation, and packaging into client-specific genetic products.
Cloud genomic analysis and interpretation platform
Cloud-hosted platform for genome-scale data analysis and interpretation intended to accelerate throughput and reduce per-sample cost.
Online gene-product customization engine
Browser-based tool providing selection from thousands of interpretation items, cost estimation, and packaging into client-specific genetic products.
Services
Turnkey service including sample kit provision, laboratory testing, data analysis, and delivery of interpretation reports.
Online platform to customize genetic product content, estimate costs, and produce editable interpretation reports.
Platform for managing genomic products, data, and user permissions for enterprise deployments.
Enterprise training, documentation, and multi-channel genetic counseling to support interpretation and product use.
Turnkey service including sample kit provision, laboratory testing, data analysis, and delivery of interpretation reports.
Online platform to customize genetic product content, estimate costs, and produce editable interpretation reports.
Platform for managing genomic products, data, and user permissions for enterprise deployments.
Enterprise training, documentation, and multi-channel genetic counseling to support interpretation and product use.
Expertise Areas
- Whole-genome and whole-exome data analysis
- Genomic variant annotation and interpretation
- Cloud-based bioinformatics platforms
- Custom genetic product development and costing
Key Technologies
- Whole-genome sequencing analysis
- Whole-exome sequencing analysis
- Cloud-based analysis pipelines
- Genomic variant annotation knowledgebase
News & Updates
ISO9001 Quality Management System Certification
GeneKang successfully obtained ISO9001 certification in July 2022.
Upgrade of Drug Module in Full Genome Series Products
In June 2022, the company upgraded the evaluation indicators for the drug guidance module of its full genome series products.
8th Anniversary Celebration
GeneKang celebrated its 8th anniversary in June 2022.
Production Process Optimization Phase I Launch
In April 2022, the company launched its first phase of production process optimization.
Product Optimization for External Exome Health Assessment
In December 2021, GeneKang upgraded its 'External Exome Health Assessment' product for enterprise clients.
Upgrade of Whole Genome Interpretation Knowledge Base
In October 2021, the knowledge base was upgraded to provide more professional reports.
ISO9001 Quality Management System Certification
GeneKang successfully obtained ISO9001 certification in July 2022.
Upgrade of Drug Module in Full Genome Series Products
In June 2022, the company upgraded the evaluation indicators for the drug guidance module of its full genome series products.
8th Anniversary Celebration
GeneKang celebrated its 8th anniversary in June 2022.
Production Process Optimization Phase I Launch
In April 2022, the company launched its first phase of production process optimization.
Product Optimization for External Exome Health Assessment
In December 2021, GeneKang upgraded its 'External Exome Health Assessment' product for enterprise clients.
Upgrade of Whole Genome Interpretation Knowledge Base
In October 2021, the knowledge base was upgraded to provide more professional reports.